Back to search results

Non-Invasive Pelvic Floor Neuromuscular Stimulation for Urinary Incontinence After Prostatectomy

This study is looking at a treatment called non-invasive pelvic floor neuromuscular stimulation for men who experience urinary incontinence (leaking urine) after prostatectomy (surgery to remove the prostate). This treatment uses a device to help strengthen pelvic floor muscles without needing active effort from you. The study aims to see if this treatment is safe and effective in improving continence. Researchers will measure changes in your symptoms using questionnaires. You may be able to join if you are a man aged 18 or older, have had a prostatectomy at UCLA, and do not have certain medical conditions like a pacemaker or active urinary tract infection. The study plans to enroll 37 participants, but its current status is unclear.

Study design
This is an interventional study with a planned enrollment of 37 men. It is not specified if it is randomized or blinded.
What's involved
Participants will complete an 8-week intervention with 12 sessions total. Outcomes will be assessed at the beginning, end of treatment, and within three months of starting the intervention.
Compensation
Not stated in the trial record.
Follow-up
Your continence and questionnaire scores will be measured up to 3 months after starting the treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07534696

Evaluation of Non-Invasive Pelvic Floor Neuromuscular Stimulation for Urinary Incontinence After Prostatectomy

Enrolling by Invitation
NAAges 18+InterventionalTreatment
University of California, Los Angeles
~37 participants
Updated 2026-05-27 on ClinicalTrials.gov
What's tested:Non-invasive pelvic floor neuromuscular stimulation

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in EPIC questionnaire score
Measured over From enrollment to 3 months after initiation of treatment
+2 more outcomes measured

Conditions

Urinary Incontinence
Prostatectomy

Explore related trials

Urinary Incontinence

Where it's being run

1 sites across 1 states
California1

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Men aged 18 years or older
Undergoing or underwent prostatectomy at UCLA
Able to provide informed consent

Exclusion

Cardiac pacemaker, implanted defibrillator, or other contraindicated metallic or electronic implants
Active urinary tract infection
Hematuria of unknown origin
Untreated bladder outlet obstruction
Neurologic conditions affecting bladder function (e.g., multiple sclerosis, Parkinson disease, spinal cord injury)
Active fever or systemic inflammatory condition at the time of treatment
Any condition deemed by the investigator to make participation unsafe

What this trial measures

  • Change in EPIC questionnaire scoreFrom enrollment to 3 months after initiation of treatment

    The Expanded Prostate Cancer Index Composite (EPIC) is a validated questionnaire assessing urinary, bowel, sexual, and hormonal outcomes.

  • Change in ICIQ-UI questionnaire scoreFrom enrollment to 3 months after initiation of treatment

    The International Consultation on Incontinence Questionnaire Urinary Incontinence (ICIQ-UI) short form is a validated questionnaire assessing urinary incontinence.

  • ContinenceFrom enrollment to 3 months after initiation of treatment

    Continence is measured by number of pads used per 24 hours, with continence defined as less than one pad used per day.